IoT in Healthcare Market by Component (Medical Device, Systems & Software, Services, and Connectivity Technology), Application (Telemedicine, Connected Imaging, and Inpatient Monitoring), End User, and Region – Global Forecast to 2025

2020-07-20
Price :
Published : Jul-2020
No. of Pages : 307

The global Internet of Things (IoT) in healthcare market size to grow at a CAGR of 21.0% during the forecast period

The IoT in healthcare market size is projected to grow from USD 72.5 billion in 2020 to USD 188.2 billion by 2025, at a Compound Annual Growth Rate (CAGR) of 21.0% during the forecast period. The IoT in healthcare market is driven by factors, such as advancement in technology coupled with rising demand for self-health management service and rise of digitalization and increase in the overall level of connectivity and innovations taking place in the modern healthcare ecosystem. However, lack of skilled digital workforce, and challenge for organizations due to security concerns related to the violation of crucial patient information are expected to retrict the growth of the IoT in healthcare market.

Systems and Software segment to grow at the highest CAGR during the forecast period

The IoT in healthcare market by component is segmented into medical devices, systems and software,  services, and connectivity technology. The systems and software segment is expected to grow at a rapid pace during the forecast period. Systems and software are the most promising components in the IoT in healthcare market as they create a high degree of smart characteristics and autonomy in the IoT ecosystem. They are designed to meet interoperability challenges that occur due to varied heterogeneous devices, along with managing large volumes of data and offering them security and privacy.

Hospitals, surgical centers, and clinics segment to hold the largest market size during 2020

The IoT in healthcare market by end user has been segmented into hospitals, surgical centers, and clinics;clinical research organizations;government and defense institutions; and research and diagnostic laboratories. IoT solutions in the healthcare sector are majorly catered by this segment that consists of hospitals, surgical centers, and clinics, as they are the most approached care centers by patients.

APAC to grow at the highest CAGR during the forecast period

Asia Pacific (APAC) is expected to grow at the highest CAGR during the forecast period. Factors, such as flexible economic conditions, industrialization- and globalization-motivated policies of the governments, as well as expanding digitalization, would support the growth of the IoT in healthcare market in the region.

In-depth interviews were conducted with Chief Executive Officers (CEOs), innovation and technology directors,system integrators, and executives from various key organizations operating in the IoT in healthcare market.

  • By Company: Tier I:35%, Tier II:45%, and Tier III:20%
  • By Designation: C-Level Executives:35%, Directors:25%, and Others:40%
  • By Region: North America: 45%, APAC: 20%, Europe: 30%, and RoW: 5%

The report includes the study of key players offering IoT in healthcare solutions and services.It 20profiles major vendors in the global IoT in healthcare market.Major vendors in the IoT in healthcare market are Agamatrix (US), Armis (US), Bosch (Germany),  Capsule Technologies (US), Comarch SA (Poland), Cisco Systems (US), GE Healthcare (US),HQ Software (Estonia), Huawei (China), IBM Corporation (US), Intel (US), KORE Wireless (US), Medtronic (Ireland), Microsoft Corporation (US), Oracle (US), OSP Labs (US),Oxagile (US),PTC (US), Resideo Technologies (US), Royal Philips (Netherlands), R-Style Labs (US), SAP SE (Germany), Sciencesoft  (US), Siemens (Germany), Softweb Solutions (US), STANLEY Healthcare (US), Telit (UK), and Welch Allyn (US).It further includes an in-depth competitive analysis of key players in the IoT in healthcare market, along with their company profiles,business overviews, product offerings, recent developments, and market strategies.

Research Coverage

The market study covers the IoT in healthcare market across segments. It aims at estimating the market size and the growth potential of this market, across different segments, such as component, application, end user, and region. The study further includes an in-depth competitive analysis of key players in the market, along with their company profiles, key observations related to product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall IoT in healthcare market and the sub segments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report further helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

Filed in: Pharmaceuticals and Healthcare
Publisher : marketsandmarkets
More Reports
Title Price Buy Now

Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (Practice Management, e-Prescribing, PHM, Health Analytics, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User – Global Forecast to 2025

“Government support to increase adoption of EHR solutions is expected to drive the overall growth of the ambulatory EHR market.” The ambulatory EHR market is expected to reach USD 6.8 billion by 2025 from USD 5.2 billion in 2020, at a CAGR of 5.7% during the forecast period of 2020 to 2025. Growth in the global ambulatory EHR market can primarily be attributed to various factors such as government support for the adoption of EHR solutions, increasing number of outpatient care centers, growing patient volume due to the global outbreak of COVID-19, and the need to curtail healthcare costs. On the other hand, market growth is limited to a certain extent due to factors such as reluctance to adopt EHR solutions in developing countries, heavy infrastructure investments, and the high cost ......
$4950

Patient Registry Software Market by Registry Type (Diabetes, Rare Disease, Cancer, Kidney), Software (Integrated, Standalone), Delivery (On Premise, Cloud), Functionality (PHM, HIE), Pricing Model, Database (Public), End User (Hospital) – Forecast to 2025

“Rising adoption of electronic health records and other e-health solutions are driving market growth” The global patient registry software market is projected to reach USD 2.4 billion by 2025 from USD 1.2 billion in 2020, at a CAGR of 14.4% from 2020 to 2025. The shift toward computerized registries from paper-based registries, due to their advantages, is a key driver of market growth. The emergence of the COVID-19 pandemic and the increase in the number of COVID-19 patients globally is also expected to support the demand for patient registry software. Other considerations include the rising number of accountable care organizations, high adoption of the subscription model, and the emergence of cloud-based patient registry solutions. However, shortage of trained and skilled resources......
$4950

ePrescribing Market by Product & Services (Solution (Integrated, Standalone), Services(Implementation, Network)),by Delivery Mode (Web & Cloud based, On premise) End User (Hospitals, Physician Offices, Pharmacies), COVID-19 Impact – Global Forecast to 2025

The global ePrescribing market size is projected to reach USD 3.3 billion by 2025 from USD 1.2 billion in 2020, at a CAGR of 23.3%.The increasing adoption of EHR solutions, government initiatives and incentive programs, rising focus on reducing the abuse of controlled substances, increasing focus on reducing medical errors, and the need to curtail the escalating healthcare costs are driving the growth of the e-prescribing market. The increased adoption of integrated telehealth solutions due to COVID-19 and the emerging APAC markets are expected to provide significant growth opportunities for players in the e-prescribing market during the forecast “The services segment is projected to witness the highest growth in the ePrescribing  market, by type of product & service, during the ......
$4950

Referral Management Market by Component (Software [Integrated, Standalone], Services), Mode of Delivery (Cloud-Based, On-Premise), Type (Inbound , Outbound), End User (Providers, Payers, Others) – Analysis & Global Forecasts to 2025

“Various government initiatives focusing on healthcare digitization and increasing adoption of healthcare IT solutions across the healthcare facilities are set to drive the referral management market.” The global referral management market is projected to reach 6.0 billion by 2025 from USD 2.8 billion in 2020 at a CAGR of 16.7%. Growth in the referral management market can be attributed to factors such as technological advancements in healthcare sector, advantages associated with automated referral processes, rising patient pool worldwide & increased funding for healthcare IT solutions. However, data security concerns and dearth of skilled healthcare IT professionals may prove to be restraints for the market growth. The COVID-19 pandemic has impacted the medical practices of ......
$490

Patient Engagement Solutions Market by Component (Hardware, Software, Services), Delivery Mode (On Premise, Cloud), End User (Provider, Payer), Applications (Home Health, Financial Health), Therapeutic Area – Analysis and Global Forecast to 2025

“The patient engagement solutions market is projected to grow at a CAGR of 10.1% due to the 5.2.1.1  Implementation of government regulations and initiatives to promote patient-centric care.” The global patient engagement solutions market is projected to reach USD 19.3 billion by 2025 from USD 11.9 billion in 2020, at a CAGR of 10.1% during the forecast period. The growth of this market is driven by the implementation of government regulations and initiatives to promote patient-centric care, increasing demand for patient engagement solutions, and the increasing utilization of mobile health apps. However, a lack of interoperability of PES and a dearth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period.......
$4950

United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others

United States In Vitro Diagnostics Market Outlook to 2025 - Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others Summary GlobalData's "United States In Vitro Diagnostics Market Outlook to 2025" is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United States In Vitro Diagnostics Market report provides key information and data on - - Annualized market revenues (USD), volume (units) and average prices (USD) data for each of t......
$5995

Organ Function Assays – Medical Devices Pipeline Assessment, 2020

Organ Function Assays - Medical Devices Pipeline Assessment, 2020 Summary GlobalData's Medical Devices sector report, "Organ Function Assays - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Organ Function Assays pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Organ Function Assays are the group of tests that reflects distinct organ dysfunction/disease. This category includes kidney, liver, pancreatic and thyroid etc. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type. Scope - Extensive coverage of the Organ Function Assays under development ......
$2500

Self Testing – Medical Devices Pipeline Assessment, 2020

Self Testing - Medical Devices Pipeline Assessment, 2020 Summary GlobalData's Medical Devices sector report, "Self Testing - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Self Testing pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Self Testing Devices are diagnostic devices enables an individual to diagnose health at home and helps to monitor disease condition using patient's sample. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type. Scope - Extensive coverage of the Self Testing Devices under development - The report reviews details of m......
$2500

Troponin Rapid Tests and Point of Care (POC) – Medical Devices Pipeline Assessment, 2020

Troponin Rapid Tests and Point of Care (POC) - Medical Devices Pipeline Assessment, 2020 Summary GlobalData's Medical Devices sector report, "Troponin Rapid Tests and Point of Care (POC) - Medical Devices Pipeline Assessment, 2020 " provides comprehensive information about the Troponin Rapid Tests & Point of Care (POC) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Troponin Rapid Tests & POC are point-of-care diagnostic tests enables to measure troponin levels specific to cardiovascular diseases in patient's sample. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type. Scope - Extens......
$2500

Hepatitis B Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 market impact)

Hepatitis B Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact) Summary Hepatitis B Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Hepatitis B Tests market for the year 2020 and beyond. Hepatitis B is a common cause of liver disease across the globe, and remains a major issue for most of the governments despite the fact that an effective vaccine has been available since 1982. The World Health Organization (WHO) recommends that all infants receive the hepatitis B vaccination and universal vaccinations have now been implemented in numerous count......
$7500
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy